Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Background: In ayurveda, sciatica can be correlated to ' under (neurological disorders caused by , one of the bodily humour). In this mainly bodily humours and are vitiating producing symptoms like piercing pain, stiffness, twitching, numbness and pain radiating from lumbosacral region to lower limb up to the foot. Therapeutic plan includes stabilizing and bringing back the vitiated vata and kapha humours to equilibrium. The prevalence of sciatica varies considerably ranging from 3.8% in the working population to 7.9% in the nonworking population.
Aim: Comparative evaluation of efficacy of and as an adjuvant to (oil pooling therapy) in the management of (Sciatica).
Objectives: To assess the efficacy of as an adjuvant to in subjective and objective parameters of (Sciatica). To assess the efficacy of as an adjuvant to in subjective and objective parameters of (Sciatica). To compare the efficacy of and as an adjuvant to in subjective and objective parameters. Standardisation of (modified formvati).
Methods: In this study, a total of 60 patients will be enrolled and divided equally into two groups. In group A, 500 mg twice a day after meal with warm water for 30 days adjuvant with katibasti for the initial 7 days will be given. In group B, 500 mg twice a day after meal with warm water adjuvant with katibasti for the initial 7 days will be given for 30 days.
Result: The result will be assessed on baseline of subjective and objective parameters and data will be compared after treatment.
Conclusions: It will be based on observations and results obtained.
Trial Registration: CTRI No. - CTRI/2022/12/048534 Dated - 27/12/2022.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487230 | PMC |
http://dx.doi.org/10.12688/f1000research.139568.3 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!